Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease‐Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta‐Analysis of Randomized Controlled Trials

Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease‐Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta‐Analysis of Randomized Controlled Trials

Objective We evaluated the efficacy and safety profiles of JAK inhibitors (JAKi) and biologic disease‐modifying antirheumatic drugs (bDMARDs) when used with or without methotrexate (MTX) for the treatment of nonsystemic forms of juvenile idiopathic arthritis (nsJIA). Methods Randomized clinical tria...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxiang Li, Bin Huang, Sandra Andorf, Xiaomeng Yue, Daniel J. Lovell, Hermine I. Brunner
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11788
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items